KRAS and benign prostatic hyperplasia: Our finding of reduced miR-143-3p in prostate cancer tissue relative to BPH is consistent with those reports and reinforces the idea that loss of miR-143 may contribute to prostate tumorigenesis by unleashing pro-proliferative pathways such as the KRAS signaling pathway.